Cargando…
Colistin dosing for treatment of multidrug-resistant Pseudomonas in critically ill patients - please, be adequate!
Autores principales: | Honoré, Patrick M, Jacobs, Rita, De Regt, Jouke, Van Gorp, Viola, De Waele, Elisabeth, Spapen, Herbert D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014864/ https://www.ncbi.nlm.nih.gov/pubmed/24602603 http://dx.doi.org/10.1186/cc13747 |
Ejemplares similares
-
Nebulized colistin for treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: we still need to straighten out the dose!
por: Honore, Patrick M., et al.
Publicado: (2015) -
Acute respiratory muscle weakness and apnea in a critically ill patient induced by colistin neurotoxicity: key potential role of hemoadsorption elimination during continuous venovenous hemofiltration
por: Honore, Patrick M, et al.
Publicado: (2013) -
Biomarkers in critical illness: have we made progress?
por: Honore, Patrick M, et al.
Publicado: (2016) -
Renal and neurological side effects of colistin in critically ill patients
por: Spapen, Herbert, et al.
Publicado: (2011) -
Critical care nephrology: could it be a model of multidisciplinarity in ICU nowadays for other sub-specialities – the jury is out
por: Honoré, Patrick M, et al.
Publicado: (2014)